Upcoming Ex-Dividend Dates for Gildan Activewear, Archer Daniels Midland, and Hasbro
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 17 2025
0mins
Source: NASDAQ.COM
Upcoming Ex-Dividend Dates: On 11/19/25, Gildan Activewear Inc (GIL), Archer Daniels Midland Co. (ADM), and Hasbro, Inc. (HAS) will trade ex-dividend, with respective dividends of $0.226, $0.51, and $0.70 scheduled for payment on 12/15/25, 12/11/25, and 12/3/25.
Expected Price Adjustments: Following the ex-dividend date, shares of Gildan Activewear Inc are expected to open 0.39% lower, Archer Daniels Midland Co. 0.87% lower, and Hasbro, Inc. 0.90% lower, based on their recent stock prices.
Dividend Yield Estimates: The estimated annualized yields for the upcoming dividends are 1.54% for Gildan Activewear Inc, 3.48% for Archer Daniels Midland Co., and 3.60% for Hasbro, Inc., reflecting their historical dividend stability.
Current Trading Performance: In recent trading, Gildan Activewear Inc shares are up about 1.8%, while Archer Daniels Midland Co. shares are down about 0.4%, and Hasbro, Inc. shares have decreased by approximately 1.5%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HAS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HAS
Wall Street analysts forecast HAS stock price to rise
9 Analyst Rating
7 Buy
1 Hold
1 Sell
Moderate Buy
Current: 95.380
Low
90.00
Averages
95.71
High
100.00
Current: 95.380
Low
90.00
Averages
95.71
High
100.00
About HAS
Hasbro, Inc. is a game, intellectual property (IP) and toy company. The Company delivers play experiences to kids, families, and fans around the world, through physical and digital games, video games, and toys, among others. Its Consumer Products segment engages in the sourcing, marketing and sales of toy and game products around the world. Its Wizards of the Coast and Digital Gaming segment engages in the promotion of the Company's brands through the development of trading cards, role-playing and digital game experiences based on Hasbro and Wizards of the Coast games. Its Entertainment segment engages in the development and production of Hasbro-branded entertainment content, including film, television, children’s programming, digital content and live entertainment focused on Hasbro-owned properties. Its portfolio of brands includes MAGIC: THE GATHERING, DUNGEONS & DRAGONS, MONOPOLY, HASBRO GAMES, NERF, TRANSFORMERS, PLAY-DOH and PEPPA PIG, as well as premier partner brands.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
New Dungeons & Dragons Series 'Dungeon Masters' Launching April 22
- Series Launch: Wizards of the Coast announces the debut of the new series 'Dungeon Masters' on April 22 on YouTube, featuring a two-episode premiere special aimed at attracting both veteran D&D players and newcomers, thereby broadening its audience base.
- Content Innovation: The series will showcase official unreleased D&D content and enhance viewer experience through innovative visuals, which is expected to increase player interest and engagement with D&D, ultimately driving brand loyalty.
- Musical Score: The series features an original score by five-time Grammy-nominated composer David Arkenstone, creating a dark, atmospheric setting filled with mystery and gothic horror, further enhancing the viewing experience and attracting a wider audience.
- Strategic Implications: This series not only pays homage to actual play shows but also integrates content from the newly announced 'Ravenloft: The Horrors Within', showcasing Wizards of the Coast's ambition to expand its entertainment product line, which is expected to enhance the brand's influence in the global market.
See More
US Stocks Close Higher Amid Optimism Over Middle East Conflict Resolution
- Market Rally: The S&P 500 rose by 0.72%, the Dow Jones increased by 0.48%, and the Nasdaq 100 climbed by 1.18%, reflecting growing investor optimism regarding a potential resolution to the Middle East conflict, which has bolstered market confidence.
- Strong Economic Data: The US ADP employment change for March increased by 62,000, surpassing expectations of 40,000, while February retail sales rose by 0.6% month-over-month, indicating robust economic recovery that could influence Federal Reserve policy decisions.
- Interest Rate Expectations: Despite positive economic indicators, hawkish comments from St. Louis Fed President raised concerns about inflation and employment, leading to a mere 1% chance of a 25 basis point rate hike at the upcoming April FOMC meeting, reflecting cautious market sentiment.
- Divergent Stock Performances: Target Hospitality surged over 36% after securing a multi-year contract worth over $550 million, while Nike fell more than 15% due to revenue forecasts indicating a decline, highlighting the market's varied outlook on different companies' futures.
See More
Eli Lilly Receives FDA Approval for New Drug Foundayo
- New Drug Approval: Eli Lilly announced that its once-daily GLP-1 drug Foundayo has received FDA approval and is set to launch on April 6 via the LillyDirect online platform, addressing strong market demand for weight loss medications and further solidifying its position in the obesity treatment market.
- Positive Market Outlook: Analysts forecast Foundayo to generate approximately $1.55 billion in sales this year, with projections growing to about $14.8 billion by 2030, indicating the drug's significant potential in the future market and its capacity to reshape obesity treatment paradigms.
- Significant Competitive Advantage: Compared to rival Novo Nordisk's Wegovy, Foundayo offers greater flexibility in dosing and dietary restrictions, and has demonstrated superior efficacy in clinical studies for diabetes patients, which may attract a broader patient base to choose this medication.
- Accelerated Strategic Transformation: Eli Lilly built up a substantial stockpile of the drug ahead of FDA approval to ensure a swift market response, showcasing the company's foresight and execution in its new drug launch strategy, thereby enhancing its competitiveness in the biopharmaceutical industry.
See More
Hasbro Reports Unauthorized Access Incident
- Security Incident Disclosure: Hasbro reported in a regulatory filing that it detected unauthorized access to its systems, indicating potential risks in cybersecurity that could impact customer trust and brand reputation.
- Impact Assessment: While specific data breach details remain unclear, this incident may raise investor concerns regarding the company's information security management capabilities, potentially affecting its stock performance.
- Regulatory Compliance: The disclosure of this incident aligns with regulatory requirements, demonstrating the company's commitment to transparency, although it may prompt scrutiny of its internal controls and data protection measures.
- Follow-up Actions: Hasbro may need to enhance cybersecurity measures and conduct internal audits to prevent similar incidents in the future, thereby maintaining its market position and customer trust.
See More
Eli Lilly Gains FDA Approval, Shares Rise
- FDA Drug Approval: Eli Lilly's once-daily GLP-1 pill Foundayo received FDA approval, leading to a 4% rise in shares, which will enhance the company's competitive edge in the obesity treatment market and drive future sales growth.
- Cybersecurity Incident Impact: Hasbro's shares fell over 4% due to a cybersecurity incident involving unauthorized network access, with the company investigating the full impact and implementing protective measures, potentially increasing operational costs in the short term.
- Tobacco Product Delay: Philip Morris International's shares dropped more than 5% after the FDA delayed authorization for nicotine pouch sales, which may hinder the company's future market expansion plans, particularly among new user demographics.
- Semiconductor Buyback Plan: Intel announced a $14.2 billion buyback of a 49% stake in its Ireland Fab 34 joint venture, resulting in a 9% increase in shares, with funding sourced from cash on hand and approximately $6.5 billion in new debt, expected to strengthen its position in the global semiconductor market.
See More
Hasbro Faces Network Breach Ahead of Earnings Call
- Network Security Incident: Hasbro (HAS) disclosed a network breach last week, prompting the company to proactively take certain systems offline, highlighting vulnerabilities in its cybersecurity that could negatively impact operations.
- Ongoing Investigation: The company stated that it is conducting an ongoing investigation to resolve the issue and determine the full scope of impact, a process that may extend recovery time and affect future financial performance.
- External Support: Hasbro is collaborating with third-party cybersecurity professionals to identify and review potentially impacted files, a move that, while enhancing security measures, may also increase operational costs in the short term.
- Market Reaction: Following this announcement, Hasbro's shares slipped into the red ahead of Thursday's open, reflecting investor concerns over the company's cybersecurity status, which could affect its upcoming earnings report.
See More
New Dungeons & Dragons Series 'Dungeon Masters' Launching April 22
- Series Launch: Wizards of the Coast announces the debut of the new series 'Dungeon Masters' on April 22 on YouTube, featuring a two-episode premiere special aimed at attracting both veteran D&D players and newcomers, thereby broadening its audience base.
- Content Innovation: The series will showcase official unreleased D&D content and enhance viewer experience through innovative visuals, which is expected to increase player interest and engagement with D&D, ultimately driving brand loyalty.
- Musical Score: The series features an original score by five-time Grammy-nominated composer David Arkenstone, creating a dark, atmospheric setting filled with mystery and gothic horror, further enhancing the viewing experience and attracting a wider audience.
- Strategic Implications: This series not only pays homage to actual play shows but also integrates content from the newly announced 'Ravenloft: The Horrors Within', showcasing Wizards of the Coast's ambition to expand its entertainment product line, which is expected to enhance the brand's influence in the global market.
See More
US Stocks Close Higher Amid Optimism Over Middle East Conflict Resolution
- Market Rally: The S&P 500 rose by 0.72%, the Dow Jones increased by 0.48%, and the Nasdaq 100 climbed by 1.18%, reflecting growing investor optimism regarding a potential resolution to the Middle East conflict, which has bolstered market confidence.
- Strong Economic Data: The US ADP employment change for March increased by 62,000, surpassing expectations of 40,000, while February retail sales rose by 0.6% month-over-month, indicating robust economic recovery that could influence Federal Reserve policy decisions.
- Interest Rate Expectations: Despite positive economic indicators, hawkish comments from St. Louis Fed President raised concerns about inflation and employment, leading to a mere 1% chance of a 25 basis point rate hike at the upcoming April FOMC meeting, reflecting cautious market sentiment.
- Divergent Stock Performances: Target Hospitality surged over 36% after securing a multi-year contract worth over $550 million, while Nike fell more than 15% due to revenue forecasts indicating a decline, highlighting the market's varied outlook on different companies' futures.
See More
Eli Lilly Receives FDA Approval for New Drug Foundayo
- New Drug Approval: Eli Lilly announced that its once-daily GLP-1 drug Foundayo has received FDA approval and is set to launch on April 6 via the LillyDirect online platform, addressing strong market demand for weight loss medications and further solidifying its position in the obesity treatment market.
- Positive Market Outlook: Analysts forecast Foundayo to generate approximately $1.55 billion in sales this year, with projections growing to about $14.8 billion by 2030, indicating the drug's significant potential in the future market and its capacity to reshape obesity treatment paradigms.
- Significant Competitive Advantage: Compared to rival Novo Nordisk's Wegovy, Foundayo offers greater flexibility in dosing and dietary restrictions, and has demonstrated superior efficacy in clinical studies for diabetes patients, which may attract a broader patient base to choose this medication.
- Accelerated Strategic Transformation: Eli Lilly built up a substantial stockpile of the drug ahead of FDA approval to ensure a swift market response, showcasing the company's foresight and execution in its new drug launch strategy, thereby enhancing its competitiveness in the biopharmaceutical industry.
See More
Hasbro Reports Unauthorized Access Incident
- Security Incident Disclosure: Hasbro reported in a regulatory filing that it detected unauthorized access to its systems, indicating potential risks in cybersecurity that could impact customer trust and brand reputation.
- Impact Assessment: While specific data breach details remain unclear, this incident may raise investor concerns regarding the company's information security management capabilities, potentially affecting its stock performance.
- Regulatory Compliance: The disclosure of this incident aligns with regulatory requirements, demonstrating the company's commitment to transparency, although it may prompt scrutiny of its internal controls and data protection measures.
- Follow-up Actions: Hasbro may need to enhance cybersecurity measures and conduct internal audits to prevent similar incidents in the future, thereby maintaining its market position and customer trust.
See More
Eli Lilly Gains FDA Approval, Shares Rise
- FDA Drug Approval: Eli Lilly's once-daily GLP-1 pill Foundayo received FDA approval, leading to a 4% rise in shares, which will enhance the company's competitive edge in the obesity treatment market and drive future sales growth.
- Cybersecurity Incident Impact: Hasbro's shares fell over 4% due to a cybersecurity incident involving unauthorized network access, with the company investigating the full impact and implementing protective measures, potentially increasing operational costs in the short term.
- Tobacco Product Delay: Philip Morris International's shares dropped more than 5% after the FDA delayed authorization for nicotine pouch sales, which may hinder the company's future market expansion plans, particularly among new user demographics.
- Semiconductor Buyback Plan: Intel announced a $14.2 billion buyback of a 49% stake in its Ireland Fab 34 joint venture, resulting in a 9% increase in shares, with funding sourced from cash on hand and approximately $6.5 billion in new debt, expected to strengthen its position in the global semiconductor market.
See More
Hasbro Faces Network Breach Ahead of Earnings Call
- Network Security Incident: Hasbro (HAS) disclosed a network breach last week, prompting the company to proactively take certain systems offline, highlighting vulnerabilities in its cybersecurity that could negatively impact operations.
- Ongoing Investigation: The company stated that it is conducting an ongoing investigation to resolve the issue and determine the full scope of impact, a process that may extend recovery time and affect future financial performance.
- External Support: Hasbro is collaborating with third-party cybersecurity professionals to identify and review potentially impacted files, a move that, while enhancing security measures, may also increase operational costs in the short term.
- Market Reaction: Following this announcement, Hasbro's shares slipped into the red ahead of Thursday's open, reflecting investor concerns over the company's cybersecurity status, which could affect its upcoming earnings report.
See More
